Anebulo Pharmaceuticals Inc (ANEB)
1.46
-0.04
(-2.67%)
USD |
NASDAQ |
Nov 22, 16:00
1.59
+0.13
(+8.90%)
After-Hours: 20:00
Anebulo Pharmaceuticals Free Cash Flow: -7.054M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.054M |
| June 30, 2024 | -8.091M |
| March 31, 2024 | -8.887M |
| December 31, 2023 | -9.580M |
| September 30, 2023 | -10.38M |
| June 30, 2023 | -9.683M |
| March 31, 2023 | -8.833M |
| Date | Value |
|---|---|
| December 31, 2022 | -8.104M |
| September 30, 2022 | -6.693M |
| June 30, 2022 | -5.437M |
| March 31, 2022 | -6.935M |
| December 31, 2021 | -6.303M |
| September 30, 2021 | -5.514M |
| June 30, 2021 | -4.871M |
Free Cash Flow Range, Past 5 Years
-10.38M
Minimum
Sep 2023
-4.871M
Maximum
Jun 2021
-7.597M
Average
-7.572M
Median
Free Cash Flow Benchmarks
| Revance Therapeutics Inc | -194.91M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.69M |
| Free Cash Flow Per Share (Quarterly) | -0.0652 |
| Free Cash Flow Yield | -18.66% |